Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 869367201 since 12/18/2024, largest first.
| Filer | % of Class | Filed | ||
|---|---|---|---|---|
|
Perceptive Advisors LLC
13G/A
|
7.9% |
8/14/2026
Event 6/30/2026
|
||
| Perceptive Advisors LLC | 7.9% | |||
| Joseph Edelman | 7.9% | |||
| Perceptive Life Sciences Master Fund, Ltd. | 7.9% | |||
|
Biotechnology Value Fund L P
13G
|
7.6% |
2/18/2026
Event 2/10/2026
|
||
| Biotechnology Value Fund L P | 4.1% | |||
| BVF I GP LLC | 4.1% | |||
| Biotechnology Value Fund II LP | 3.0% | |||
| BVF II GP LLC | 3.0% | |||
| Biotechnology Value Trading Fund OS LP | 0.5% | |||
| BVF Partners OS Ltd. | 0.5% | |||
| BVF GP Holdings LLC | 7.0% | |||
| BVF Partners L P/IL | 7.6% | |||
| BVF Inc/IL | 7.6% | |||
| Lampert Mark N | 7.6% | |||
|
Affinity Asset Advisors, LLC
13G/A
|
6.5% |
5/14/2026
Event 3/31/2026
|
||
| Affinity Asset Advisors, LLC | 6.5% | |||
| Michael Cho | 6.5% | |||
| BlackRock, Inc. 13G | 6.4% |
7/30/2026
Event 6/30/2026
|
||
|
Samsara BioCapital, L.P.
13G
|
6.4% |
5/15/2026
Event 2/11/2026
|
||
| Samsara BioCapital, L.P. | 2.5% | |||
| Samsara BioCapital GP, LLC | 2.5% | |||
| Samsara Opportunity Fund, L.P. | 3.9% | |||
| Samsara Opportunity Fund GP, LLC | 3.9% | |||
| Srinivas Akkaraju | 6.4% | |||
| Under 5%, checked the "5 percent or less" box, or amended by a later filing (2) | ||||
|
Point72 Asset Management, L.P.
13G/A
|
1.4% |
8/14/2026
Event 6/30/2026
|
||
| Point72 Asset Management, L.P. | 1.4% | |||
| Point72 Capital Advisors, Inc. | 1.4% | |||
| Steven A. Cohen | 1.4% | |||
|
Millennium Management LLC
13G/A
|
1.3% |
4/21/2026
Event 3/31/2026
|
||
| Millennium Management LLC | 1.3% | |||
| Millennium Group Management LLC | 1.3% | |||
| Israel A. Englander | 1.3% | |||